• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Serbia’s Punim Plućima joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as the Serbian Punim Plućima (Lung Cancer Patient […]

Call To Action: Survey for 9th LuCE Report

Lung Cancer Europe (LuCE) has launched of an important new survey, together with 39 of its Member Organisations.This survey will […]

Association of Patients with Respiratory Failure and Lung Transplantation joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as the Bulgarian Association of Patients with Respiratory […]

LuCE seeks to fill key roles

Join our team at Lung Cancer Europe (LuCE) and become part of a dedicated group of individuals who are driven […]

ALK Positive Europe joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as Alk Positive Europe joins the LuCE family. […]

Alk+ France cancer poumon joins Lung Cancer Europe

We are very happy that Alk Ros1 France Cancer Poumon has become a member of Lung Cancer Europe (LuCE).Alk+ France […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]

Five new members join the Lung Cancer Europe (LuCE) network

We’re delighted to welcome five new member organisations to our growing Lung Cancer Europe (LuCE) network. These organisations and their […]

New LuCE Board elected at AGM 2024 in Zagreb

We are delighted to announce the new Board of Lung Cancer Europe (LuCE) elected at our AGM in Zagreb last […]

Busy schedule planned for AGM 2024 in Zagreb

Lung Cancer Europe (LuCE) Annual General Meeting and General Assembly The Lung Cancer Europe (LuCE) AGM and General Assembly take […]